Stroke Risk Stratification: CHA₂DS₂-VA or CHA₂DS₂-VASc?

Heart Lung Circ. 2019 May;28(5):e103. doi: 10.1016/j.hlc.2018.09.013.

Authors

David Brieger¹, Cia Connell², Ben Freedman³

Affiliations

¹ Department of Cardiology, Concord Hospital, Sydney, Australia; University of Sydney, Sydney, Australia. Electronic address: david.brieger@health.nsw.gov.au.
² The National Heart Foundation of Australia, Melbourne, Australia.
³ Sydney Medical School, The University of Sydney, Sydney, Australia; Heart Research Institute, Charles Perkins Centre, University of Sydney, Sydney, Australia.

PMID: 30935621
DOI: 10.1016/j.hlc.2018.09.013

No abstract available

Publication types

Letter

MeSH terms

Administration, Oral
Aged
Anticoagulants / therapeutic use*
Atrial Fibrillation / complications
Atrial Fibrillation / drug therapy*
Atrial Fibrillation / physiopathology
Australia
Female
Humans
Male
Middle Aged
Practice Guidelines as Topic
Sex Factors
Stroke / etiology
Stroke / physiopathology
Stroke / prevention & control*

Substances

Anticoagulants